BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6192923)

  • 1. Increased urinary levels of RNA catabolites in mice as early indicators for malignant growth.
    Thomale J; Luz A; Nass G
    Cancer Detect Prev; 1983; 6(1-2):73-6. PubMed ID: 6192923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing urinary levels of modified nucleosides and bases during tumor development in mice.
    Thomale J; Nass G
    Recent Results Cancer Res; 1983; 84():378-87. PubMed ID: 6844699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excretion of modified nucleosides during development of malignant lymphomas in mice after whole body irradiation.
    Thomale J; Luz A; Nass G
    J Cancer Res Clin Oncol; 1984; 108(3):302-7. PubMed ID: 6392304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated urinary excretion of RNA catabolites as an early signal of tumor development in mice.
    Thomale J; Nass G
    Cancer Lett; 1982 Feb; 15(2):149-59. PubMed ID: 6178502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary excretion of modified nucleosides in patients with malignant mesothelioma.
    Fischbein A; Sharma OK; Selikoff IJ; Borek E
    Cancer Res; 1983 Jun; 43(6):2971-4. PubMed ID: 6850607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Excretion of normal and modified RNA catabolites and creatinine in the urine as a function of nutrition in children].
    Schöch G; Heller-Schöch G; Müller J; Clemens P; Holtgrewe A; Heddrich M
    Monatsschr Kinderheilkd; 1983 May; 131(5):259-63. PubMed ID: 6192333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of urinary nucleosides as biological marker in cancer patients analyzed by micellar electrokinetic capillary chromatography.
    Zheng YF; Xu GW; Liu DY; Xiong JH; Zhang PD; Zhang C; Yang Q; Lv S
    Electrophoresis; 2002 Dec; 23(24):4104-9. PubMed ID: 12481266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of modified nucleosides in the urine of patients with malignant cancer by liquid chromatography/electrospray ionization mass spectrometry.
    Li HY; Wang SM; Liu HM; Li J; Han D; Bu SS; Zhang MZ
    Rapid Commun Mass Spectrom; 2008 Oct; 22(20):3161-71. PubMed ID: 18798199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excretion pattern investigation of urinary normal and modified nucleosides of breast cancer patients by RP-HPLC and factor analysis method.
    Xu G; Schmid HR; Lu X; Liebich HM; Lu P
    Biomed Chromatogr; 2000 Nov; 14(7):459-63. PubMed ID: 11113924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multilayer perceptron tumour diagnosis based on chromatography analysis of urinary nucleosides.
    Seidel P; Seidel A; Herbarth O
    Neural Netw; 2007 Jul; 20(5):646-51. PubMed ID: 17275256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gas chromatography/mass spectrometric analysis of urinary nucleosides in cancer patients; potential of modified nucleosides as tumour markers.
    Langridge JI; McClure TD; el-Shakawi S; Fielding A; Schram KH; Newton RP
    Rapid Commun Mass Spectrom; 1993 Jun; 7(6):427-34. PubMed ID: 8329765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of urinary excretion of modified nucleosides.
    Gehrke CW; Kuo KC; Waalkes TP; Borek E
    Cancer Res; 1979 Apr; 39(4):1150-3. PubMed ID: 421198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of urinary nucleosides as potential tumor markers in human colorectal cancer by high performance liquid chromatography/electrospray ionization tandem mass spectrometry.
    Hsu WY; Chen WT; Lin WD; Tsai FJ; Tsai Y; Lin CT; Lo WY; Jeng LB; Lai CC
    Clin Chim Acta; 2009 Apr; 402(1-2):31-7. PubMed ID: 19135043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NTP Toxicology and Carcinogenesis Studies of 2,2-Bis(Bromomethyl)-1,3-Propanediol (FR-1138(R)) (CAS No. 3296-90-0) in F344 Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 May; 452():1-465. PubMed ID: 12594523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary catabolites of ribonucleic acid as cancer markers: a preliminary report of their use in patients with lung cancer.
    Mackenzie JW; Lewis RJ; Sisler GE; Lin W; Rogers J; Clark I
    Ann Thorac Surg; 1984 Aug; 38(2):133-9. PubMed ID: 6087748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The detection of genetic markers of bladder cancer in urine and serum.
    Lodde M; Fradet Y
    Curr Opin Urol; 2008 Sep; 18(5):499-503. PubMed ID: 18670274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NTP Toxicology and Carcinogenesis Studies of o-Nitroanisole (CAS No. 91-23-6) in F344 Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 May; 416():1-482. PubMed ID: 12616295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicology and carcinogenesis studies of indium phosphide (CAS No. 22398-90-7) in F344/N rats and B6C3F1 mice (inhalation studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2001 Jul; (499):7-340. PubMed ID: 12087422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Significance of urinary nucleosides in diagnosis of gastric carcinoma].
    Chen YJ; Zheng YF; Wang NF; Lu S; Pang T; Yang Q; Xu GW
    Ai Zheng; 2003 May; 22(5):537-40. PubMed ID: 12753721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.